Regulon

Regulon: R-2844

Regulons are regulatory units consisting of a coherently expressed set of genes and the associated regulator(s) whose binding site(s) they share.

Regulon Summary

Regulon summary table displays all associated information related to the specific regulon including the number of genes in the regulon, Hazard ratio, its Regulator, the Transcriptional Program that includes the regulon, Drugs that are associated with members of the regulon, together with mechanism of action and class, and enriched hallmarks of cancer if any.

GenesCox Hazard RatioRegulatorsCausal FlowsTranscriptional ProgramsHallmarks
16-2.5246616Pr-59Self sufficiency in growth signalInsensitivity to antigrowth signalEvading apoptosisSustained angiogenesisTissue invasion and metastasisTumor-promoting inflammationReprogramming energy metabolismEvading immune detectionLimitless replicative potentialGenome instability and mutation

Regulon Genes

List of genes that are included in the regulon. These genes have similar expression profiles in subset of patients and they share common binding motif for the Regulator of the regulon. Clicking on the gene name will take you to the gene specific page with more details. Please wait while information is collated from several resources after you click.

Entrez IDEnsEMBL IDPreferred NameUniprot ID
10771 ENSG00000015171 ZMYND11 Q15326
23304 ENSG00000024048 UBR2 Q8IWV8
23041 ENSG00000061987 MON2 Q7Z3U7
10203 ENSG00000064989 CALCRL Q16602
657 ENSG00000107779 BMPR1A P36894
80351 ENSG00000107854 TNKS2 Q9H2K2
81847 ENSG00000118518 RNF146 Q9NTX7
51347 ENSG00000135090 TAOK3 Q9H2K8
9712 ENSG00000148429 USP6NL Q92738
2746 ENSG00000148672 GLUD1 P00367
6934 ENSG00000148737 TCF7L2 Q9NQB0
9425 ENSG00000153046 CDYL Q9Y232
27185 ENSG00000162946 DISC1 C4P092
54861 ENSG00000163788 SNRK Q9NRH2
9079 ENSG00000169744 LDB2 O43679
9867 ENSG00000198961 PJA2 O43164

Regulon Drugs

NameApproved SymbolTypeAction TypeMechanism of ActionMax Trial PhaseMax GBM Phase
RIMEGEPANT SULFATECALCRLSmall moleculeANTAGONISTCalcitonin gene-related peptide type 1 receptor antagonist40
TELCAGEPANTCALCRLSmall moleculeANTAGONISTCalcitonin gene-related peptide type 1 receptor antagonist30
ATOGEPANTCALCRLSmall moleculeANTAGONISTCalcitonin gene-related peptide type 1 receptor antagonist40
UBROGEPANTCALCRLSmall moleculeANTAGONISTCalcitonin gene-related peptide type 1 receptor antagonist40
ERENUMABCALCRLAntibodyANTAGONISTCalcitonin gene-related peptide type 1 receptor antagonist40
2X-121TNKS2Small moleculeINHIBITORPoly [ADP-ribose] polymerase-1 inhibitor20
RIMEGEPANTCALCRLSmall moleculeANTAGONISTCalcitonin gene-related peptide type 1 receptor antagonist40
BI-44370CALCRLSmall moleculeANTAGONISTCalcitonin gene-related peptide type 1 receptor antagonist20
MK3207CALCRLSmall moleculeANTAGONISTCalcitonin gene-related peptide type 1 receptor antagonist20
DAVALINTIDERAMP1ProteinAGONISTCalcitonin gene-related peptide type 1 receptor agonist20
OLCEGEPANTCALCRLSmall moleculeANTAGONISTCalcitonin gene-related peptide type 1 receptor antagonist20

Causal Flows

Causal Flows are statistically significant links between putative causal events (somatic mutations, copy number variations, chromosomal translocations, etc.) and the activity levels of regulators and regulons. In the causal flow a mutation may causally activates or deactivates a downstream regulator which then might up- or down-regulates a regulon that contains genes with similar expression profiles and binding sites.

Causal Mechanistic Flows for Regulon R-2844

IDMutationRoleRegulatorRoleRegulon# downstream regulons# diffexp regulonsDrugs
CMF-03951DSPdown-regulatesNKX6-1repressesR-28442015Drugs (11)
CMF-07942SLC27A2down-regulatesNKX6-1repressesR-2844204Drugs (11)
CMF-08821FBLN2down-regulatesNKX6-1repressesR-2844208Drugs (11)
CMF-12181CELSR1down-regulatesNKX6-1repressesR-2844206Drugs (11)
CMF-16081NFIXdown-regulatesNKX6-1repressesR-2844206Drugs (11)
CMF-18923TEAD1down-regulatesNKX6-1repressesR-2844202Drugs (11)